Coskun Arslandemir

Most-cited papers

1. Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer.

   H. Schirrmeister, G. Glatting, J. Hetzel, K. Nüssle +6 more

   2001Journal of Nuclear Medicine297 citations

   Semantic Scholar

   Save

2. F‐18 NaF PET for Detection of Bone Metastases in Lung Cancer: Accuracy, Cost‐Effectiveness, and Impact on Patient Management

   M. Hetzel, Coskun Arslandemir, H. König, A. Buck +6 more

   2003Journal of Bone and Mineral Research179 citations Open access

   Semantic Scholar

   Save

3. Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer

   H. Schirrmeister, Coskun Arslandemir, G. Glatting, R. Mayer-Steinacker +4 more

   2004European Journal of Nuclear Medicine and Molecular Imaging54 citations

   Semantic Scholar

   Save

4. Reliability of symptoms to determine use of bone scans to identify bone metastases in lung cancer: prospective study

   M. Hetzel, J. Hetzel, Coskun Arslandemir, K. Nüssle +1 more

   2004British medical journal28 citations Open access

   Semantic Scholar

   Save

5. Diagnosis of Skeletal Metastases in Malignant Extraskeletal Cancers

   H. Schirrmeister, Coskun Arslandemir

   20103 citations

   Semantic Scholar

   Save

6. In comparison to F18-sodium fluoride PET the extent of metastatic bone disease is underestimated with FDG in lung cancer patients

   Coskun Arslandemir, U. Lützen, A. Buck, N. Czech +3 more

   20070 citations

   Semantic Scholar

   Save

7. Bone scanning in lung cancer: Authors' reply

   M. Hetzel, Coskun Arslandemir, H. Schirrmeister

   2004British medical journal0 citations Open access

   Semantic Scholar

   Save

8. Bone scanning in lung cancer

   R. Benamore, J. Entwisle, M. Peake, M. Hetzel +2 more

   20040 citations

   Semantic Scholar

   Save